SML3412
Talinolol
≥95% (HPLC)
别名:
(±)-Talinolol, 02-115, 1-(4-(3-(tert-Butylamino)-2-hydroxypropoxy)phenyl)-3-cyclohexylurea, 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane, Cordanum, N-Cyclohexyl-N′-[4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]urea, rac-Talinolol
登录 查看组织和合同定价。
选择规格
变更视图
关于此项目
经验公式（希尔记法）:
C20H33N3O3
化学文摘社编号:
分子量:
363.49
UNSPSC Code:
51111800
NACRES:
NA.77
MDL number:
Assay:
≥95% (HPLC)
Form:
powder
Storage condition:
desiccated
Quality Segment
assay
≥95% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
SMILES string
N(C2CCCCC2)C(=O)Nc1ccc(cc1)OCC(O)CNC(C)(C)C
InChI
1S/C20H33N3O3/c1-20(2,3)21-13-17(24)14-26-18-11-9-16(10-12-18)23-19(25)22-15-7-5-4-6-8-15/h9-12,15,17,21,24H,4-8,13-14H2,1-3H3,(H2,22,23,25)
InChI key
MXFWWQICDIZSOA-UHFFFAOYSA-N
Biochem/physiol Actions
Orally active beta-adrenergic receptor (βAR1/2, bAR1/2) antagonist (β blocker, beta blocker) with additional soluble epoxide hydrolase (sEH) inhibitory potency.
Talinolol is an orally active beta blocker (β blocker) with in vivo antihypertensive efficacy. In addition to its beta-adrenergic receptor (βAR, bAR) antagonist potency (βAR1/2 Ki = 0.24/0.9 μM), talinolol is also reported to exhibit inhibitory side-activity against soluble epoxide hydrolase (sEH IC50 = 2.8 μM).
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable